Thousands of cancer patients in Pakistan are facing difficulties accessing newly registered life-saving medicines as approvals for the prices of 40 drugs remain pending with the federal government. The delay has prevented these medicines from being legally sold in the country, forcing many patients and families to rely on expensive imports and informal supply channels. […]